SCM
HAE icon

Sio Capital Management’s Haemonetics HAE Stock Holding History

Sio Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-220,672
Closed -$12.4M – 75
2026
Q1 		$12.4M Buy
220,672
+128,041
+138% +$8.34M 1.78% 17
2025
Q4 		$7.42M Sell
92,631
-105,404
-53% -$7.08M 1.17% 24
2025
Q3 		$9.65M Buy
+198,035
New +$12.3M 2.44% 14
2025
Q2 		– Sell
-133,966
Closed -$8.51M – 55
2025
Q1 		$8.51M Buy
+133,966
New +$9.11M 2.54% 13

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's HAE Position: Q2 2026 in Review

Sio Capital Management sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 220,672 shares — an estimated $12.4M sold.

Sio Capital Management first reported a position in HAE in Q1 2025 and held it in 4 quarters. The position peaked at $12.4M in Q1 2026. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Sio Capital Management reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 220,672 Haemonetics shares in Q2 2026, an estimated $12.4M.
  • Sio Capital Management first reported a position in Haemonetics in Q1 2025 and held it in 4 quarters.
  • Sio Capital Management's Haemonetics position peaked at $12.4M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.